| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Proteasome degradation 0.5233658513646495 3.033045272268689 0.0024209927678993 0.7554418660358639 0.348006604294139 41 P28072,O00233,Q9UL46,P25789,P28074,P25788,P10321,P49721,P49720,Q99436,P20618,P28070 12 |
| Folate metabolism 0.7638852154079963 2.9338270553578365 0.0033481070744509 0.8575143448832557 0.348006604294139 13 P00374,Q8WTV0,P41440 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.535084239564737 2.393665105124511 0.0166809718028053 0.9999430529094184 0.4734371575159531 27 P48449,Q8WTV0,Q15436,Q15437 4 |
| Mitochondrial complex i assembly model oxphos system 0.5804740952819459 2.3809415910246328 0.0172684497867678 0.9999597582929644 0.4734371575159531 21 O96000,Q9NPL8,Q9BQ95,O75306,Q9BUB7,O95168,O43676,Q7L592,O43674 9 |
| Ciliopathies 0.6599684399156196 2.367121376851873 0.0179270524360601 0.9999727405179902 0.4734371575159531 13 P36405,Q86Y56,Q15555,Q8TD19,Q10713,Q9UBB4,Q96EX3,Q9BW83,O43924 9 |
| Apoptosis 0.727112947436384 2.314743110617139 0.0206269949547115 0.9999944936597156 0.4833017065219934 10 O00221,Q9NR28 2 |
| Fluoropyrimidine activity 0.6762977123367343 2.311665668182098 0.0207961147384678 0.999995019334667 0.4833017065219934 12 P00374,Q99808,Q9BZX2 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.819955227604521 2.235595988004901 0.0253782476412989 0.9999996735819682 0.5265986385569527 6 Q16850,Q15392,Q9UBM7 3 |
| Apoptosis modulation and signaling 0.6264213527028986 2.176663185986641 0.029505706974267 0.9999999722716012 0.5329043536837541 13 O95831,Q9NR28 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5506965167139088 2.1759944004480327 0.0295556792640538 0.999999973088876 0.5329043536837541 21 Q15392,P48449,Q16850,O75845,Q9UBM7 5 |
| Nanomaterial induced apoptosis 0.8607957902919995 2.156459977852597 0.0310477656640266 0.999999988992819 0.5329043536837541 5 O95831,Q9NR28 2 |
| Ethanol effects on histone modifications 0.7288714585145383 2.15469827719385 0.0311854527112696 0.999999989865124 0.5329043536837541 8 P00374,P41440 2 |
| Cytosine methylation 0.9165844642191666 2.119871109037235 0.0340169164406765 0.9999999981494888 0.5489952347786958 4 P48735 1 |
| Pancreatic adenocarcinoma pathway 0.559001730761548 2.0100717851741 0.0444235917750173 0.9999999999965784 0.6154334515288832 18 P30086,Q16611,P27361,P11802,P11233 5 |
| Nucleotide metabolism 0.6202901686359725 2.0039750270634435 0.045072735606624 0.9999999999976946 0.6154334515288832 12 P00374,P31350 2 |
| Cholesterol biosynthesis pathway 0.6195025389018233 1.999585094175932 0.0455450848218705 0.9999999999982706 0.6154334515288832 12 P48449,Q16850,O75845,Q9UBM7 4 |
| Vitamin b12 metabolism 0.7180050776223551 1.9297646392535637 0.0536360067160928 0.9999999999999876 0.626327046761179 7 Q8WTV0,Q99707 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.5766489895280866 1.9221244323373607 0.0545901024575874 0.9999999999999932 0.626327046761179 14 O43772 1 |
| Histone modifications 0.801095962550728 1.90943096610665 0.0562065192908018 0.9999999999999974 0.626327046761179 5 Q9H7B4 1 |
| Onecarbon metabolism 0.5791197282526982 1.9022779616544496 0.0571348252639285 0.9999999999999986 0.626327046761179 13 P00374,Q99707,P34897 3 |
| Disorders of folate metabolism and transport 0.7007145260535573 1.849803525093348 0.0643418726170561 1.0 0.675729500665284 7 P00374,Q99707 2 |
| Hepatitis b infection 0.5335862411701199 1.8443609502532512 0.0651305542809912 1.0 0.675729500665284 18 Q16531,P63104,Q15750,Q9Y277,Q15904,Q7Z434,P31751,P27361,P49327,P62993,P12004 11 |
| Myometrial relaxation and contraction pathways 0.5433965042192851 1.797265761406405 0.0722934389957226 1.0 0.688565377975653 16 Q99439,P63104,P78417,P19174,P62258,Q04917,P0DP25 7 |
| Nonsmall cell lung cancer 0.5474841795201789 1.7154294466194009 0.0862665204609727 1.0 0.7498402054762258 13 P42771,Q9HC35,Q16611,P31751,P27361,P62993,P11802,Q13043 8 |
| Oxysterols derived from cholesterol 0.6931807723498605 1.6774976275148743 0.0934452130049519 1.0 0.7498402054762258 6 O14734,Q9UBM7 2 |
| Transsulfuration and onecarbon metabolism 0.498308189440429 1.6698840676816016 0.0949423031447411 1.0 0.7498402054762258 19 P00374,Q99707 2 |
| Sphingolipid metabolism in senescence 0.6008430574365019 1.665081086148512 0.0958965796272246 1.0 0.7498402054762258 10 Q06136 1 |
| Alzheimers disease and mirna effects 0.3374206221784144 1.6235121867276137 0.1044799603477657 1.0 0.7587857120256488 75 O00233,Q9UJX6,P45880,P49721,P49720,P0DP25,P28072,P27361,Q9BUF5,P20618,P28070,O00487,P21796,P49841,P25789,P28074,P25788,Q99436,P60900 19 |
| Oxidative phosphorylation 0.4452743872471719 1.5963953412138514 0.1104005556334382 1.0 0.7664996788513885 24 O96000,Q16718,O75306,O75964,Q15904,O95168,O43674 7 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.6737123504715349 1.589509664186597 0.1119453739481564 1.0 0.7664996788513885 6 P51812,P06730 2 |
| Alzheimers disease 0.3327876986505969 1.5759976932216606 0.115026334832704 1.0 0.7664996788513885 74 P28072,O00233,Q9UJX6,O00487,P49841,P25789,P20618,P28074,P25788,P45880,P49721,P27361,P49720,P21796,Q99436,P0DP25,P60900,P28070 18 |
| Genes related to primary cilium development based on crispr 0.5814337072713208 1.5622880270607336 0.1182201512918605 1.0 0.7664996788513885 10 Q9BW83,P36405,Q96EX3,A0AVF1 4 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6677047532905608 1.5622665324153484 0.1182252127638614 1.0 0.7664996788513885 6 P06730,Q96KB5 2 |
| Statin inhibition of cholesterol production 0.76961207594994 1.5315934595256084 0.1256227875113595 1.0 0.7805942087232619 4 Q8WTV0 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.6321554868583708 1.5279097160430233 0.1265349555351729 1.0 0.7805942087232619 7 P06730,P49770,Q96B36 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5481738706990366 1.4849351777695692 0.1375609963253865 1.0 0.7805942087232619 11 P55209,P48729,P49841,O60725,P11802 5 |
| Mthfr deficiency 0.6976043959166485 1.469368843724553 0.1417327732142916 1.0 0.7805942087232619 5 Q7L592 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7525063869051539 1.4617176392788398 0.1438186014882787 1.0 0.7805942087232619 4 P07099 1 |
| Tcell activation sarscov2 0.5210988790936233 1.4403603865830683 0.1497654649758211 1.0 0.7805942087232619 12 Q9H1B7,P27361,P62993,P49841 4 |
| Selenium micronutrient network 0.5182661122207196 1.424047689045293 0.1544326676550753 1.0 0.7805942087232619 12 Q8WTV0 1 |
| Oxidative damage response 0.7358203273696198 1.3934177033219917 0.1634935153578098 1.0 0.7805942087232619 4 O00221,P60953,Q16611 3 |
| Angiopoietinlike protein 8 regulatory pathway 0.4176067160027624 1.3817504431702228 0.1670483400801821 1.0 0.7805942087232619 24 O00767,P49841,P51812,P54619,P41440,P27361,Q9UPT5,P06730 8 |
| Pyrimidine metabolism 0.3819640988076998 1.3594885491407 0.1739918285988642 1.0 0.7805942087232619 33 P17812,P30085,Q9NR33,Q9NRF8,Q9H773,P62487,Q9BZX2,P31350 8 |
| Common pathways underlying drug addiction 0.6217394318708399 1.352785478555426 0.1761241732208542 1.0 0.7805942087232619 6 P62140,P27361 2 |
| Complement system in neuronal development and plasticity 0.5639094820584776 1.3444331445145103 0.1788083619024552 1.0 0.7805942087232619 8 Q9NR28 1 |
| Rala downstream regulated genes 0.6676017926048678 1.3400053720459637 0.1802435984287345 1.0 0.7805942087232619 5 P16989,P11233,Q96KP1 3 |
| Target of rapamycin tor signaling 0.5600290963800174 1.324953271770679 0.1851866503145691 1.0 0.7892772573899677 8 P60953,P62942,Q96B36 3 |
| Autophagy 0.7176664894242597 1.3190269957270393 0.1871600875549335 1.0 0.7892772573899677 4 P54619,Q96B36 2 |
| Cerebral organic acidurias including diseases 0.6604061582516734 1.308942011580709 0.1905539942924232 1.0 0.7892772573899677 5 P48735 1 |
| Allograft rejection 0.5860068346177436 1.308317150092439 0.1907657605219679 1.0 0.7892772573899677 7 Q9BY49,P10321,P08183,P04439 4 |
| Melatonin metabolism and effects 0.8642069227843292 1.2986655461737688 0.1940587329293117 1.0 0.7892772573899677 2 P42892 1 |
| Glycogen synthesis and degradation 0.4930761010938951 1.2789393682940582 0.200918407880172 1.0 0.8017989386890814 12 P63151,P0DP25,P30153 3 |
| Glutathione metabolism 0.5792103589108282 1.2759120787591425 0.2019866007621125 1.0 0.8017989386890814 7 O75874 1 |
| 3q29 copy number variation syndrome 0.5392830642201301 1.2750835655177697 0.2022796656770686 1.0 0.8017989386890814 9 Q96EX3,O95684,P02786 3 |
| 16p112 distal deletion syndrome 0.577106675660823 1.2658828435338223 0.2055550296002695 1.0 0.8017989386890814 7 P20338,P62993 2 |
| 7oxoc and 7betahc pathways 0.5441947462325257 1.245463317797432 0.21296149121663 1.0 0.8086969045546538 8 O14734,Q9UBM7 2 |
| Cellular proteostasis 0.6447067783701473 1.2411771029417022 0.2145403314024705 1.0 0.8094021593820478 5 P61758,Q9NQP4,Q99471,O15212 4 |
| Nonalcoholic fatty liver disease 0.3443388450018954 1.2301019192878793 0.2186589414426247 1.0 0.8143643908856729 40 O96000,O75251,Q16718,O75306,P49841,P20674,P54619,P14406,P60953,O95168,O43676,Q16611,O43674,P05198 14 |
| Complement system 0.5213762820433577 1.1825479245787442 0.2369883614034469 1.0 0.8376974343180874 9 P26885,P08754 2 |
| Mecp2 and associated rett syndrome 0.4491983451732459 1.1727284872411572 0.2409047037860894 1.0 0.8376974343180874 15 Q14353,P35637,Q13148,P31943,P67809,P52597 6 |
| Oxidation by cytochrome p450 0.680870488827179 1.1683705189288678 0.2426573413559349 1.0 0.8376974343180874 4 Q16850 1 |
| Hepatitis c and hepatocellular carcinoma 0.5284559463401841 1.1665552795718297 0.2433900121662029 1.0 0.8376974343180874 8 P31350,P62993 2 |
| Oxidative stress response 0.6272639809045284 1.1659872461661691 0.2436196020383638 1.0 0.8376974343180874 5 P48506,P09601,Q16881 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5269932603376933 1.1592324798697904 0.2463614354988696 1.0 0.8376974343180874 8 P27361,P49841,Q05086 3 |
| Disruption of postsynaptic signaling by cnv 0.5545408655585539 1.1584200692146602 0.2466926530569855 1.0 0.8376974343180874 7 P27361,Q7L576 2 |
| Methionine de novo and salvage pathway 0.5238982743147035 1.1437456488197624 0.2527291360590529 1.0 0.8376974343180874 8 P19623,Q13126,Q99707 3 |
| Pparalpha pathway 0.5510440277450854 1.141801395295276 0.2535365822566633 1.0 0.8376974343180874 7 P50416,P11802 2 |
| Mapk cascade 0.6727057099766955 1.1350382391268123 0.2563592968432724 1.0 0.8376974343180874 4 P62993 1 |
| Phosphodiesterases in neuronal function 0.8197033092430592 1.1202084692974663 0.2626249357056691 1.0 0.840741150794814 2 O43924 1 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.3599218947070896 1.1068467470074592 0.2683601931459936 1.0 0.8410989330971956 31 P49841,P51812,P60953,Q7L576,P67809,Q96P70,P27361,P62993,P06730 9 |
| Nitric oxide metabolism in cystic fibrosis 0.6131050892180684 1.1051194739688293 0.2691078233831279 1.0 0.8410989330971956 5 Q99873,O60678 2 |
| Il5 signaling pathway 0.4937284649569161 1.094922593585695 0.2735505498125916 1.0 0.8410989330971956 10 P62993,P49841 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4317336690370452 1.0912124019246587 0.2751794320207337 1.0 0.8410989330971956 16 Q9UJX6,P49841,Q16611,P27361,Q96KP1,P11233 6 |
| G1 to s cell cycle control 0.4054608879702094 1.0864480732787527 0.2772808026534874 1.0 0.8410989330971956 20 P35244,P42771,Q9Y619,P27694,P12004,P24941,P11802 7 |
| Influence of laminopathies on wnt signaling 0.5082233717580029 1.0655224594824293 0.2866395675615227 1.0 0.8410989330971956 8 O60725,P48729,P49841 3 |
| Glycosylation and related congenital defects 0.4956989941492179 1.0505175254158037 0.293480237698231 1.0 0.8432666503173987 9 P34949,Q9Y5P6,O60762,Q2TAA5 4 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.5040682811507277 1.044862029254908 0.2960867412474171 1.0 0.8432666503173987 8 Q8IXH7 1 |
| Striated muscle contraction pathway 0.6490484785185994 1.0388582088287928 0.2988706849658378 1.0 0.8455272295668381 4 P67936 1 |
| Il9 signaling pathway 0.5524589519632963 1.036881544680644 0.2997910659049374 1.0 0.8455272295668381 6 P62993 1 |
| Il1 signaling pathway 0.4989959857008229 1.0196938875312214 0.3078736615048996 1.0 0.8548549441184817 8 Q9BQ95,P27361,Q15750 3 |
| Il6 signaling pathway 0.4865658759265612 1.0038889716331385 0.3154321328758094 1.0 0.8644625905700248 9 P62993,P49841 2 |
| T cell receptor and costimulatory signaling 0.5853008377760928 0.9863691825828524 0.3239519819624201 1.0 0.8647857754941001 5 P19174,P20936,P48729,P49841 4 |
| Translation factors 0.3301482395142728 0.9721716984923016 0.3309651377053528 1.0 0.8647857754941001 36 P49770,Q9H074,P55010,Q14232,O75153,P60842 6 |
| Epo receptor signaling 0.5113200162607354 0.9544111179215972 0.339875580693163 1.0 0.8647857754941001 7 P27361,P62993 2 |
| Onecarbon metabolism and related pathways 0.4338099039262785 0.9413135525101992 0.3465441996440086 1.0 0.8647857754941001 12 Q99707,P48637,O43865,P48506,P00390,P34897,P32929 7 |
| Endometrial cancer 0.4323825450297647 0.9333389360063638 0.35064499786067 1.0 0.8647857754941001 12 Q16611,P62993,Q9UJX6,P49841 4 |
| Heme biosynthesis 0.6218119887283375 0.9292468919103704 0.3527611511051665 1.0 0.8647857754941001 4 P36551 1 |
| Thermogenesis 0.3552348568274426 0.9215867990861154 0.3567441468227352 1.0 0.8708754172437361 25 O43772,P50416,P51812,P54619,P62993,Q96B36,O60341 7 |
| Folatealcohol and cancer pathway hypotheses 0.7668314948649692 0.912417393210961 0.3615490368830716 1.0 0.8742135124591617 2 Q99707 1 |
| Melanoma 0.4090735197535031 0.9080402235772476 0.3638569704901524 1.0 0.8742135124591617 14 Q16611,P0DP25,P11802,P62993 4 |
| Il7 signaling pathway 0.5234437116636595 0.9065819751119764 0.3646278971374781 1.0 0.8742135124591617 6 P49841 1 |
| Il10 antiinflammatory signaling pathway 0.5654701081364741 0.9026469090110536 0.3667133219169811 1.0 0.8742135124591617 5 P09601 1 |
| Urea cycle and metabolism of amino groups 0.47142431491121 0.8842400152924401 0.3765666615035461 1.0 0.8787602041883809 8 P19623,Q14353 2 |
| Nuclear receptors in lipid metabolism and toxicity 0.7584632940281493 0.8801953546269379 0.3787534895898994 1.0 0.8787602041883809 2 P28288 1 |
| Tnfalpha signaling pathway 0.4003110683583885 0.8753005506205204 0.381410394611489 1.0 0.8787602041883809 15 Q16543,Q9NR28,O00221,P27361,P63208,P62993 6 |
| Tgfbeta receptor signaling 0.5567523590588084 0.8661939964340397 0.3863837851041831 1.0 0.8787602041883809 5 P62942 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5567523590588084 0.8661939964340397 0.3863837851041831 1.0 0.8787602041883809 5 P62942 1 |
| Il17 signaling pathway 0.6050015417237227 0.8624666712314742 0.3884307658702768 1.0 0.8787602041883809 4 P49841 1 |
| Biomarkers for pyrimidine metabolism disorders 0.5074844270594654 0.8360102366725796 0.4031491442338963 1.0 0.8840455293048818 6 P31350 1 |
| 15q112 copy number variation syndrome 0.7476265225649956 0.8348810219176093 0.4037847011797675 1.0 0.8840455293048818 3 Q7L576 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4145303721251784 0.8346599889701226 0.4039091755113244 1.0 0.8840455293048818 12 Q96AY3,O75718 2 |
| Tcell receptor tcr signaling pathway 0.3931749646121572 0.8331790851459151 0.4047437363082591 1.0 0.8840455293048818 15 Q16512,P46109,P60953,P19174,P27361,P62993,O95999 7 |
| Retinoblastoma gene in cancer 0.2984092164305059 0.7957248595796186 0.4261919742822255 1.0 0.9129691991190104 40 P00374,Q13309,Q9Y619,Q16204,P40938,P31350,P11802 7 |
| Head and neck squamous cell carcinoma 0.4218555631982877 0.7948452984828287 0.4267034972496319 1.0 0.9129691991190104 11 P62942,P11802 2 |
| G13 signaling pathway 0.4058841440581956 0.7877017600846269 0.4308711758109718 1.0 0.9129691991190104 12 Q13576,P07737,Q7L576,P62140 4 |
| Pdgfrbeta pathway 0.4509108559436286 0.7855549285456154 0.4321282784126126 1.0 0.9129691991190104 8 P27361,P62993,P20936 3 |
| Interactions between loxl4 and oxidative stress pathway 0.7325979459870693 0.7821809615679958 0.4341082315641844 1.0 0.9138292845608376 2 Q9BQ95 1 |
| Bile acids synthesis and enterohepatic circulation 0.7267687563629099 0.7621191112764294 0.4459889175200273 1.0 0.9287890465755464 3 P51114 1 |
| Cysteine and methionine catabolism 0.4673713493077619 0.7528914224961768 0.4515151629254594 1.0 0.9287890465755464 7 P48506,Q99707,P32929 3 |
| Signal transduction through il1r 0.7162419170787393 0.7216606182467247 0.4705031601854399 1.0 0.9358812732537696 2 Q9BQ95 1 |
| Tlr4 signaling and tolerance 0.7162419170787395 0.7216606182467239 0.4705031601854403 1.0 0.9358812732537696 2 Q15629 1 |
| Metapathway biotransformation phase i and ii 0.3607123838367185 0.7165078615001804 0.4736778149889877 1.0 0.936077586763952 18 P07099,Q16850,Q8NCH0,P78417 4 |
| Insulin signaling 0.3009313973361923 0.703746717663629 0.4815905209449018 1.0 0.9415312497762318 35 P49841,P51812,P20338,P41440,P62993,Q6ZWJ1,P06730 7 |
| Dna mismatch repair 0.3574853339442096 0.6972129439409178 0.4856695395704822 1.0 0.9415312497762318 18 P41440,Q9NR33,Q9UQ84 3 |
| Ppar signaling pathway 0.3736623789520905 0.6934380085367648 0.4880347165520446 1.0 0.9419848122246706 13 O00767,P23786,P50416,Q15067 4 |
| Proteoglycan biosynthesis 0.6987447698744793 0.658419776322953 0.5102684310764407 1.0 0.9441591033611848 2 Q8NCH0 1 |
| Relationship between inflammation cox2 and egfr 0.5428838881556273 0.6250822310866959 0.5319170894182084 1.0 0.9687894324513452 4 Q9H7Z7,P27361 2 |
| Mirna regulation of prostate cancer signaling pathways 0.4140618173549231 0.6153151923999368 0.5383465863521377 1.0 0.9774355208456 8 P62993 1 |
| Dna replication 0.3141962886043082 0.609003893264384 0.5425218583160174 1.0 0.9788981356571618 23 P41440,Q9Y619 2 |
| Kit receptor signaling pathway 0.3548259933607673 0.5940848476948669 0.5524553648121775 1.0 0.9831023088562644 13 P51812,P62993 2 |
| Congenital generalized lipodystrophy cgl 0.6770635222518094 0.5825750110259704 0.5601794316476072 1.0 0.9831023088562644 2 P62993 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.5304553418862699 0.5800668205720381 0.5618695575568917 1.0 0.9831023088562644 4 P48506,P09601 2 |
| Serotonin htr1 group and fos pathway 0.4825350763442543 0.5701009805517554 0.5686092101433076 1.0 0.9831023088562644 5 P27361 1 |
| Egfegfr signaling pathway 0.2820591494928672 0.5461651190345128 0.5849524406860733 1.0 0.9973731460866144 34 P30086,Q16512,P00403,P16949,P46109,P51812,P60953,P62993,P12004,P20936,P11233 11 |
| Pdgf pathway 0.340561072988026 0.5311228737896999 0.595333634371346 1.0 1.0 14 Q16512,P00403,P60953,P27361,P62993,P20936 6 |
| Fragile x syndrome 0.2783916060839362 0.5204731959240753 0.6027338052065865 1.0 1.0 34 P50416,Q7L576,Q06787,P62993,P62136,P06730,Q96B36,P60842 8 |
| Egfr tyrosine kinase inhibitor resistance 0.349547086546671 0.5023538022364833 0.6154186695802233 1.0 1.0 12 P06730,P62993,P49841 3 |
| Liver x receptor pathway 0.6515785469760393 0.4976341451912617 0.6187419324799659 1.0 1.0 2 O00767 1 |
| Interferon type i signaling pathways 0.3333245708685258 0.4955699369273391 0.6201978677124473 1.0 1.0 14 P23588,Q99873,P46109,P06730,P60842 5 |
| Hippoyap signaling pathway 0.6496766831494893 0.4914998351601674 0.6230729686626091 1.0 1.0 2 Q13043 1 |
| Adipogenesis 0.3330435677775095 0.4865535669418531 0.6265747357091842 1.0 1.0 13 O00767,P17096,P43490,P14174 4 |
| Spinal cord injury 0.3215919491092896 0.4759335622580547 0.6341217106204806 1.0 1.0 17 P27361,P62942,P11802 3 |
| Modulators of tcr signaling and t cell activation 0.3681295372417199 0.4742957309705863 0.6352890353540175 1.0 1.0 10 O96000,Q15366,P19174,P62993,O95999,Q15370 6 |
| Resistin as a regulator of inflammation 0.495687738081931 0.4602981876876477 0.6453022018502748 1.0 1.0 4 P31751,P27361 2 |
| Il3 signaling pathway 0.3487389454080761 0.4427780739921048 0.657926264141584 1.0 1.0 11 P27361,P62993,P46109 3 |
| Endothelin pathways 0.3886630846325424 0.426729824229885 0.6695761250528667 1.0 1.0 7 P42892 1 |
| Electron transport chain oxphos system in mitochondria 0.2426942013629633 0.4174993383844281 0.6763132081391505 1.0 1.0 44 O96000,O75251,Q16718,P00403,O75306,P20674,P14406,Q9UII2,O75964,Q9Y6N1,O95168,O43676,O43674,P06576 14 |
| Ras signaling 0.2782583748883757 0.3958871129484036 0.6921883084179121 1.0 1.0 23 Q16512,P61020,P60953,P31751,P27361,Q13043,P62993,Q96KP1,P0DP25,P20936,P11233 11 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3236340116196031 0.3886315722503702 0.6975487079221403 1.0 1.0 12 P11802,P27361,P62993,P49841 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3749710475585985 0.3773592622478562 0.7059066368541171 1.0 1.0 7 P20338 1 |
| Network map of sarscov2 signaling pathway 0.2776944301488511 0.3657911033958662 0.7145209589699644 1.0 1.0 22 Q9P253,Q7Z434,Q08380,P06730,P31350,Q96B36,Q99829 7 |
| Tryptophan metabolism 0.3025697602203615 0.3579144677189146 0.7204073233241395 1.0 1.0 14 Q16836,Q15392,Q99873 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3037168367302787 0.3578750206289927 0.7204368449950762 1.0 1.0 13 P55010,P05198,O00303 3 |
| B cell receptor signaling pathway 0.301578251457684 0.3538825984224023 0.7234268687131036 1.0 1.0 14 P46109,P49841,P60953,P19174,P62993,O95999 6 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3494876517661621 0.3534419365791988 0.7237571510735743 1.0 1.0 8 P61020,P27361,P31943 3 |
| Ferroptosis 0.2717426268111177 0.3372693175528198 0.7359138871200719 1.0 1.0 22 P09601,P45880,Q15366,Q9Y277,Q16881,P02786,Q9NZ45,Q9NZZ3,Q15365,P16435,P32929 11 |
| Orexin receptor pathway 0.2957934723653411 0.3364889236692303 0.736502202770956 1.0 1.0 15 P31350,P27361,Q13595 3 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.5853981932199086 0.3302731319503524 0.7411935925505582 1.0 1.0 3 P48506 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.5829528158295174 0.3241509644653184 0.7458237440492226 1.0 1.0 3 P48506,P09601 2 |
| Oncostatin m signaling pathway 0.3188150626102182 0.3240711480661385 0.7458841696969205 1.0 1.0 11 P62993 1 |
| Male infertility 0.2904106241169057 0.3220602760024566 0.7474070313933348 1.0 1.0 16 Q99707,Q15645,P41440,P08183,P17096,Q9UFC0 6 |
| Synaptic vesicle pathway 0.3161040343480843 0.3143005906387091 0.7532927496729691 1.0 1.0 11 O00429 1 |
| Chemokine signaling pathway 0.2851669344103634 0.3119977963600299 0.7550421980562374 1.0 1.0 17 P27361,P62993,P49841,P08754 4 |
| Degradation pathway of sphingolipids including diseases 0.3715022308818932 0.3104626240521536 0.756209177880055 1.0 1.0 6 P06865,P17900 2 |
| P38 mapk signaling pathway 0.3703833605529018 0.307048421437113 0.7588065161866839 1.0 1.0 6 P60953,P62993 2 |
| Physicochemical features and toxicityassociated pathways 0.287381143832742 0.30400124535111 0.7611269423803302 1.0 1.0 15 P35080,P07737,P62993 3 |
| Small cell lung cancer 0.3325447409892548 0.2958424817203517 0.7673503786107825 1.0 1.0 8 Q16611,P31751,P63208,P11802 4 |
| Kisspeptinkisspeptin receptor system in the ovary 0.437671297236087 0.2869145898685697 0.7741777188522645 1.0 1.0 4 P27361 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4349544361573787 0.2797798617209914 0.779646402950261 1.0 1.0 4 Q16611 1 |
| Purine metabolism and related disorders 0.2815292403707679 0.2756004975118479 0.7828549274999932 1.0 1.0 13 P00491,P00492,Q06203,Q9BY32 4 |
| Pi3kakt signaling pathway 0.2460949263302381 0.2725844120304085 0.7851726957287255 1.0 1.0 28 P63151,P49841,P62993,P06730,P30153,P11802 6 |
| Il2 signaling pathway 0.3145701261544876 0.2712477162087072 0.7862005158471121 1.0 1.0 10 P62993 1 |
| Methylation pathways 0.5600817112819646 0.2697895214409587 0.787322184689224 1.0 1.0 3 P21964 1 |
| Tp53 network 0.5705591479650094 0.2674309119944013 0.7891374015368275 1.0 1.0 2 P42771 1 |
| Microrna network associated with chronic lymphocytic leukemia 0.5705591479650094 0.2674309119944013 0.7891374015368275 1.0 1.0 2 Q07820 1 |
| Lncrnamediated mechanisms of therapeutic resistance 0.5705591479650095 0.2674309119944007 0.789137401536828 1.0 1.0 2 P08183 1 |
| Pathogenic escherichia coli infection 0.2666189003277778 0.2649920285745224 0.7910156026487214 1.0 1.0 19 Q92747,Q13885,P63104,P60953,P07437,Q13509,Q9BUF5,Q92974,O15511,P27348 10 |
| Purine metabolism 0.3189197723303368 0.2536851001044393 0.799738845976157 1.0 1.0 8 P00491,P00492,Q9BY32 3 |
| Riboflavin and coq disorders 0.5517503805174943 0.2513389945840777 0.8015520292106366 1.0 1.0 3 Q8NFF5,Q16134 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3836161077671541 0.2511026622614489 0.8017347376498767 1.0 1.0 5 P06730 1 |
| Cardiac hypertrophic response 0.3142453840749629 0.2401278768772418 0.8102311237212843 1.0 1.0 8 P49841 1 |
| Leptin signaling pathway 0.2524854492768928 0.2400854880261219 0.8102639841257135 1.0 1.0 21 P06730,P49841,P27361,P62993 4 |
| Sarscov2 b117 variant antagonises innate immune activation 0.5534423735260595 0.2282221461474314 0.8194735455618554 1.0 1.0 2 Q7Z434 1 |
| S1p receptor signal transduction 0.3377225782773014 0.2167947412509511 0.8283683103781547 1.0 1.0 6 P27361 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.3173832332817216 0.204633375645767 0.8378585771646763 1.0 1.0 7 Q16543,O00170,P24941 3 |
| Ciliary landscape 0.2086606464045973 0.20426673723861 0.8381450617768313 1.0 1.0 94 Q8TD19,Q92905,Q9UBW8,Q13576,O95400,P61106,P43034,Q92600,Q96P70,P61962,Q96KP1,Q96EX3,Q9UPT5,Q16718,A0AVF1,O15173,Q13868,Q99627,O00471,P60660,O43805,Q9H7D7,P10619,Q9BW83 24 |
| Erbb signaling pathway 0.2484073478520417 0.1860163159361156 0.8524319663673614 1.0 1.0 16 Q16512,P46109,P49841,P31751,P27361,P62993 6 |
| Thyroid stimulating hormone tsh signaling pathway 0.2435015290519953 0.1718731983424872 0.8635372176318432 1.0 1.0 15 Q02750,P08754,P24941,P42224,P04899,Q14160,P28482,P27361,P42345,P40763,Q15418,P27695,P11802,P62753 14 |
| Thyroid hormones production and peripheral downstream signaling effects 0.238380779835874 0.1606652004395342 0.8723570993256706 1.0 1.0 15 Q96B36,P62993,P49841 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.2974995521071922 0.1600282045559851 0.8728588565027593 1.0 1.0 7 Q96B36 1 |
| Glioblastoma signaling pathways 0.2381029854450269 0.1588828951349169 0.8737611372073906 1.0 1.0 14 P42771,P31751,P27361,P62993,P24941,P11802 6 |
| Hijack of ubiquitination by sarscov2 0.3415841584158371 0.1574895502874723 0.8748590427905025 1.0 1.0 5 Q13617,Q15369,Q15370,Q8TBC4 4 |
| Ampactivated protein kinase ampk signaling 0.2560606954849191 0.146774081390398 0.8833103431476819 1.0 1.0 11 P54619,P31751,O00763,P50416 4 |
| Alpha 6 beta 4 signaling pathway 0.2901015313842476 0.1455275995637923 0.8842943263963863 1.0 1.0 7 P62993 1 |
| Il4 signaling pathway 0.273228019699441 0.142222672844144 0.88690412348568 1.0 1.0 8 P62993 1 |
| Mitochondrial immune response to sarscov2 0.2723617172645902 0.1405704739919145 0.8882092749241621 1.0 1.0 8 Q7Z434,Q9BQ95 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.3674897105506118 0.1359960893265284 0.8918243725082886 1.0 1.0 4 O00170 1 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.193213172478962 0.1290607619398542 0.8973095697165079 1.0 1.0 30 P23588,P49841,P61106,P27361,P62993,P06730,Q96B36,P30153 8 |
| Measles virus infection 0.2169914575538787 0.1257874220066615 0.8999001984707242 1.0 1.0 17 P05198,Q16611,Q7Z434,P63244,P11802,P24941,O15372 7 |
| Translation inhibitors in chronically activated pdgfra cells 0.2091012196122491 0.1124645241527998 0.9104550968743632 1.0 1.0 15 P23588,Q14240,P27361,P06730,P60842 5 |
| Amino acid metabolism 0.1321597714183003 0.1099060715950911 0.9124838672816478 1.0 1.0 53 O75874,P49419 2 |
| Parkinubiquitin proteasomal system pathway 0.166613765815006 0.1075395492066488 0.9143609514957016 1.0 1.0 34 P68036,Q13885,O00233,O00487,P07437,Q13509,O00232,Q9BUF5,Q9UNE7,Q15008,O43242,O75832,O00231,Q0VDF9,O14936,Q9UNM6 16 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.2770850291720069 0.1016642876331379 0.919023149568344 1.0 1.0 6 P49841 1 |
| Leukocyteintrinsic hippo pathway functions 0.3359031752111556 0.0916536083596468 0.9269732573435496 1.0 1.0 4 P51153,Q13043 2 |
| Micrornas in cardiomyocyte hypertrophy 0.1837280366692202 0.0896282445169877 0.9285826388518784 1.0 1.0 13 Q02750,Q08209,P49841,Q15750,Q13144,P63000,Q9P2K5,P31751,P27361,P40763,P42345,P28482 12 |
| 22q112 copy number variation syndrome 0.1489443378119055 0.0830762357678779 0.9337909216241786 1.0 1.0 26 P62826,Q92890,P53350,P45973,P00367,P46109,Q8WYQ5,O14980,Q9NVA2,P21964,Q13618,P43487,P60953,P18754,P62805,Q14974,Q9NQC3,Q92973,P24928,Q9BW71,P04637,O95721,Q8IZ69,P04181,P62140 25 |
| Microtubule cytoskeleton regulation 0.1691542288557237 0.0822935504169182 0.934413283047758 1.0 1.0 18 Q16512,Q99661,P16949,P49841,P17612,Q7Z460,P06493,P60953,Q16555,Q96GD4,P46821,P63000,Q13153,Q9Y281,P40763,Q15691,Q7KZI7 17 |
| Wntbetacatenin signaling pathway in leukemia 0.327553202656497 0.0822920689001636 0.9344144611312885 1.0 1.0 4 P49841 1 |
| Tolllike receptor signaling pathway 0.2463064338416579 0.0822153467817967 0.934475469793206 1.0 1.0 7 Q15750,P27361 2 |
| Alanine and aspartate metabolism 0.3216596878568658 0.0762466110942869 0.9392229002992868 1.0 1.0 4 P14868,P11498,P17174 3 |
| Regulatory circuits of the stat3 signaling pathway 0.2246697445376118 0.074698103569416 0.940454916591878 1.0 1.0 8 Q96B36 1 |
| Leptin and adiponectin 0.4342171906957272 0.0738602826656704 0.9411215593303676 1.0 1.0 3 P50416 1 |
| Follicle stimulating hormone fsh signaling pathway 0.2464761904761943 0.0688349748326353 0.9451209782112407 1.0 1.0 6 P17612,Q15382,P28482,P27361,P42345 5 |
| Mirna biogenesis 0.3999238964992289 0.0494144076021669 0.9605890465824528 1.0 1.0 3 Q9HAV4,P62826 2 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.4153670597185291 0.045570763328438 0.9636523724376262 1.0 1.0 2 P09543 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.3921330425568883 0.0452352450203795 0.9639198015285876 1.0 1.0 3 P31751 1 |
| Dual hijack model of vif in hiv infection 0.3763318112633093 0.0381041492658807 0.9696046430786154 1.0 1.0 3 Q93034,Q15370 2 |
| Exrna mechanism of action and biogenesis 0.3997717763408187 0.0377571752692437 0.9698812891903064 1.0 1.0 2 Q9HAV4 1 |
| Cancer immunotherapy by pd1 blockade 0.3721461187214455 0.0364924205950662 0.970889722174672 1.0 1.0 3 Q06124,P04439 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.3561643835616328 0.0312836777693164 0.9750433072905932 1.0 1.0 3 P42224,Q7Z434 2 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3561643835616328 0.0312836777693164 0.9750433072905932 1.0 1.0 3 P42224,Q7Z434 2 |
| Angiotensin ii receptor type 1 pathway 0.3367579908675688 0.0266899091895588 0.9787070615669892 1.0 1.0 3 Q06124,P63244 2 |
| Steroid biosynthesis 0.3537466717383085 0.0239103172641762 0.9809241446498176 1.0 1.0 2 Q99829 1 |
| Ras and bradykinin pathways in covid19 0.3366298972993576 0.0212754919029947 0.9830258940418732 1.0 1.0 2 Q99829 1 |
| Erk pathway in huntingtons disease 0.3366298972993578 0.0212754919029947 0.9830258940418732 1.0 1.0 2 P42858 1 |
|
|
